Compile Data Set for Download or QSAR
Report error Found 20 Enz. Inhib. hit(s) with all data for entry = 50019655
TargetLysine-specific histone demethylase 1A(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50621411(CHEMBL5433883)
Affinity DataIC50: 1nMAssay Description:Inhibition of LSD1 (unknown origin)More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
PubMed
TargetLysine-specific histone demethylase 1A(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50621410(CHEMBL5439167)
Affinity DataIC50: 1.40nMAssay Description:Inhibition of LSD1 (unknown origin)More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
PubMed
TargetLysine-specific histone demethylase 1A(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50153586(CHEMBL3775474 | US10053456, 120 | US9718814, 71 | ...)
Affinity DataIC50: 2.90nMAssay Description:Irreversible inhibition of LSD1 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
PubMed
TargetLysine-specific histone demethylase 1A(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50153586(CHEMBL3775474 | US10053456, 120 | US9718814, 71 | ...)
Affinity DataIC50: 2.90nMAssay Description:Inhibition of LSD1 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
PubMed
TargetLysine-specific histone demethylase 1A(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50403544(CHEMBL5286191)
Affinity DataIC50: 2.90nMAssay Description:Inhibition of LSD1 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
PubMed
TargetREST corepressor 1(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50153586(CHEMBL3775474 | US10053456, 120 | US9718814, 71 | ...)
Affinity DataIC50: 3.30nMAssay Description:Inhibition of recombinant human LSD1 (172 to 852 residues)/His-tagged human CoREST (286 to 482 residues) expressed in Escherichia coli BL21 (DE3) cel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
PubMed
TargetREST corepressor 1(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50621408(CHEMBL5399284)
Affinity DataIC50: 7.20nMAssay Description:Inhibition of recombinant human LSD1 (172 to 852 residues)/His-tagged human CoREST (286 to 482 residues) expressed in Escherichia coli BL21 (DE3) cel...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
PubMed
TargetREST corepressor 1(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50621404(CHEMBL5421067)
Affinity DataIC50: 14nMAssay Description:Inhibition of recombinant human LSD1 (172 to 852 residues)/His-tagged human CoREST (286 to 482 residues) expressed in Escherichia coli BL21 (DE3) cel...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
PubMed
TargetREST corepressor 1(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM256729(US9487511, 125 | US10053456, 125 | US9718814, 125 ...)
Affinity DataIC50: 46nMAssay Description:Inhibition of recombinant human LSD1 (172 to 852 residues)/His-tagged human CoREST (286 to 482 residues) expressed in Escherichia coli BL21 (DE3) cel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
PubMed
TargetREST corepressor 1(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50621401(CHEMBL5403890)
Affinity DataIC50: 82nMAssay Description:Inhibition of recombinant human LSD1 (172 to 852 residues)/His-tagged human CoREST (286 to 482 residues) expressed in Escherichia coli BL21 (DE3) cel...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
PubMed
TargetREST corepressor 1(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50621404(CHEMBL5421067)
Affinity DataIC50: 98nMAssay Description:Inhibition of recombinant human LSD1 (172 to 852 residues)/His-tagged human CoREST (286 to 482 residues) expressed in Escherichia coli BL21 (DE3) cel...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
PubMed
TargetREST corepressor 1(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50621403(CHEMBL5433869)
Affinity DataIC50: 160nMAssay Description:Inhibition of recombinant human LSD1 (172 to 852 residues)/His-tagged human CoREST (286 to 482 residues) expressed in Escherichia coli BL21 (DE3) cel...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
PubMed
TargetREST corepressor 1(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50621405(CHEMBL5418529)
Affinity DataIC50: 230nMAssay Description:Inhibition of recombinant human LSD1 (172 to 852 residues)/His-tagged human CoREST (286 to 482 residues) expressed in Escherichia coli BL21 (DE3) cel...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
PubMed
TargetREST corepressor 1(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50621406(CHEMBL5436851)
Affinity DataIC50: 270nMAssay Description:Inhibition of recombinant human LSD1 (172 to 852 residues)/His-tagged human CoREST (286 to 482 residues) expressed in Escherichia coli BL21 (DE3) cel...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
PubMed
TargetREST corepressor 1(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50153587(US9487511, 82 | CHEMBL3775248 | US10053456, 82 | U...)
Affinity DataIC50: 270nMAssay Description:Inhibition of recombinant human LSD1 (172 to 852 residues)/His-tagged human CoREST (286 to 482 residues) expressed in Escherichia coli BL21 (DE3) cel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
PubMed
TargetREST corepressor 1(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50621400(CHEMBL5406255)
Affinity DataIC50: 860nMAssay Description:Inhibition of recombinant human LSD1 (172 to 852 residues)/His-tagged human CoREST (286 to 482 residues) expressed in Escherichia coli BL21 (DE3) cel...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
PubMed
TargetREST corepressor 1(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50621402(CHEMBL5399880)
Affinity DataIC50: 1.80E+3nMAssay Description:Inhibition of recombinant human LSD1 (172 to 852 residues)/His-tagged human CoREST (286 to 482 residues) expressed in Escherichia coli BL21 (DE3) cel...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
PubMed
TargetREST corepressor 1(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50621409(CHEMBL5397545)
Affinity DataIC50: 3.70E+3nMAssay Description:Inhibition of recombinant human LSD1 (172 to 852 residues)/His-tagged human CoREST (286 to 482 residues) expressed in Escherichia coli BL21 (DE3) cel...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
PubMed
TargetREST corepressor 1(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50621407(CHEMBL5440326)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of recombinant human LSD1 (172 to 852 residues)/His-tagged human CoREST (286 to 482 residues) expressed in Escherichia coli BL21 (DE3) cel...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
PubMed
TargetREST corepressor 1(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50621399(CHEMBL5421844)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of recombinant human LSD1 (172 to 852 residues)/His-tagged human CoREST (286 to 482 residues) expressed in Escherichia coli BL21 (DE3) cel...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
PubMed